Kevin Judice
CEO at DiCE Molecules | South San Francisco, California, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
30M
Company Profiles
Find anyone, anywhere
with ContactOut today
Making remote or global hires? Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Kevin Judice, a seasoned leader in the biotechnology sector, brings over 25 years of extensive experience to his role as CEO and co-founder of DICE Therapeutics. Under his guidance, DICE has emerged as a pioneering force in the development of innovative therapeutic solutions, particularly in the realm of targeted protein modulation. The company’s recent acquisition by Eli Lilly and Co. in August 2023 marks a significant milestone in its trajectory, solidifying its position within the pharmaceutical landscape and expanding its capabilities for drug discovery and development.
Throughout his career, Kevin has demonstrated a profound expertise in the biotechnology and pharmaceuticals industries, with a strong focus on research and development (R&D) and startup growth. His previous ventures, including his role as Acting CSO and co-founder at Cidara Therapeutics and as founder, CEO, and CSO at Achaogen, have equipped him with a unique blend of strategic vision and operational acumen. At DICE Therapeutics, Kevin has spearheaded key projects that leverage cutting-edge technologies to address unmet medical needs, particularly in autoimmune diseases.
Kevin’s leadership style emphasizes collaboration and innovation, fostering an environment where scientific inquiry can thrive. His adeptness at securing non-dilutive capital has been instrumental in driving the company’s growth and advancing its pipeline of drug candidates. As DICE Therapeutics continues to integrate into Eli Lilly, Kevin remains committed to harnessing his extensive knowledge and experience to propel the company’s mission forward, ensuring that it remains at the forefront of biotechnology advancements.
CEO at DiCE Molecules in August 2013 to Present
Member, Scientific Advisory Board at Calibr at Scripps Research in June 2014 to March 2020
Founder, Cidara Therapeutics at Cidara Therapeutics in January 2012 to January 2015
Founder, CSO, CEO at Achaogen in May 2004 to October 2011
Henry Crown Fellow at The Aspen Institute in January 2008 to January 2010
Senior Director, Medicinal Chemistry at Genentech in January 2002 to January 2004
Vice President, Chemistry at Theravance Biopharma, Inc. in January 1997 to January 2002
Scientist at Genentech in January 1993 to January 1997
See more
See less
University of California, Berkeley in January 1990 to January 1993
University of California, Los Angeles in January 1985 to January 1990
Texas A&M University in January 1981 to January 1985
See more
See less
What is Kevin Judice email address?
Email Kevin Judice at [email protected] and [email protected]. This email is the most updated Kevin Judice's email found in 2024.
How to contact Kevin Judice?
To contact Kevin Judice send an email to [email protected] or [email protected].
What company does Kevin Judice work for?
Kevin Judice works for DiCE Molecules
What is Kevin Judice's role at DiCE Molecules?
Kevin Judice is CEO
What is Kevin Judice's Phone Number?
Kevin Judice's phone (213) ***-*239
What industry does Kevin Judice work in?
Kevin Judice works in the Biotechnology industry.
Kevin Judice Email Addresses
Kevin Judice Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
Top Searched People
English singer
Baseball pitcher
American singer-songwriter
Canadian-American commentator and former speechwriter
People like Kevin Judice
CEO at Golden Vibes, LLC
Sr. Director of Business Development at Culture Biosciences
President at Cativer Bio Insights
Senior Director, Key Accounts Leader at Alkermes
VP Engineering at Outlier AI
Co-Founder at Particle
Founder at Candice Nicole Public Relations
Vice President, People and Culture at Point32Health
Vice President Marketing at Starship
Investor & Board Director at Hopin
Director of Marketing at Harrison Corporation
Board Member at Marijuana Policy Project
Founder at Morris Consulting LLC
President at Felipe Gregorio Cigars
Advisor/Mentor at MaRS Discovery District
Principal at Bohlin Cywinski Jackson
Financial Advisor / Founder at AdviseAir
Chief, Vascular and Endovascular Surgery at McLaren Bay Region
Board Member at Imagina Children's Foundation, Inc.
Show more
Show less